Bausch Health Companies Inc. Quarterly Costs and Expenses in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Bausch Health Companies Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q3 2024.
  • Bausch Health Companies Inc. Costs and Expenses for the quarter ending September 30, 2024 was $2.19B, a 1.44% decline year-over-year.
  • Bausch Health Companies Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $8.12B, a 0.65% decline year-over-year.
  • Bausch Health Companies Inc. annual Costs and Expenses for 2023 was $7.79B, a 1.62% increase from 2022.
  • Bausch Health Companies Inc. annual Costs and Expenses for 2022 was $7.67B, a 3.93% decline from 2021.
  • Bausch Health Companies Inc. annual Costs and Expenses for 2021 was $7.98B, a 8.61% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $8.12B $2.19B -$32M -1.44% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $8.16B $2.01B +$259M +14.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $7.9B $1.87B +$103M +5.82% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $7.79B $2.05B -$383M -15.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $8.18B $2.22B +$422M +23.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $7.76B $1.76B -$51M -2.82% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $7.81B $1.77B +$136M +8.33% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $7.67B $2.43B +$600M +32.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $7.07B $1.8B +$265M +17.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $6.81B $1.81B -$564M -23.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $7.37B $1.63B -$615M -27.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $7.98B $1.83B -$389M -17.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $8.37B $1.54B -$141M -8.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $8.51B $2.37B +$679M +40.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $7.84B $2.25B +$484M +27.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $7.35B $2.22B -$1.08B -32.8% Oct 1, 2020 Dec 31, 2020 8-K 2021-05-04
Q3 2020 $8.43B $1.68B -$202M -10.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $8.64B $1.69B -$204M -10.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $8.84B $1.76B +$35M +2.02% Jan 1, 2020 Mar 31, 2020 8-K 2021-05-04
Q4 2019 $8.8B $3.3B +$1.2B +57.4% Oct 1, 2019 Dec 31, 2019 8-K 2021-05-04
Q3 2019 $7.6B $1.88B -$139M -6.89% Jul 1, 2019 Sep 30, 2019 8-K 2021-05-04
Q2 2019 $7.74B $1.9B -$478M -20.1% Apr 1, 2019 Jun 30, 2019 8-K 2021-05-04
Q1 2019 $8.22B $1.73B -$2.55B -59.6% Jan 1, 2019 Mar 31, 2019 8-K 2021-05-04
Q4 2018 $10.8B $2.1B -$389M -15.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-19
Q3 2018 $11.2B $2.02B -$162M -7.43% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-19
Q2 2018 $11.3B $2.37B +$315M +15.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-19
Q1 2018 $11B $4.28B +$2.38B +125% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-19
Q4 2017 $8.62B $2.49B +$232M +10.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-20
Q3 2017 $8.39B $2.18B -$1.16B -34.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-20
Q2 2017 $9.55B $2.06B -$281M -12% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-20
Q1 2017 $9.83B $1.9B -$408M -17.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-20
Q4 2016 $10.2B $2.25B -$337M -13% Oct 1, 2016 Dec 31, 2016 8-K 2018-08-10
Q3 2016 $10.6B $3.34B +$1B +42.9% Jul 1, 2016 Sep 30, 2016 8-K 2018-08-10
Q2 2016 $9.57B $2.34B -$52M -2.18% Apr 1, 2016 Jun 30, 2016 8-K 2018-08-10
Q1 2016 $9.63B $2.31B +$706M +44.1% Jan 1, 2016 Mar 31, 2016 8-K 2018-08-10
Q4 2015 $8.92B $2.59B +$972M +60.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 $7.95B $2.34B +$967M +70.5% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 $6.98B $2.39B +$705M +41.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 $6.28B $1.6B +$70.4M +4.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 $6.21B $1.62B -$222M -12.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-04-29
Q3 2014 $6.43B $1.37B -$1.06B -43.6% Jul 1, 2014 Sep 30, 2014 10-K 2016-04-29
Q2 2014 $7.49B $1.69B +$732M +76.7% Apr 1, 2014 Jun 30, 2014 10-K 2016-04-29
Q1 2014 $6.76B $1.53B +$578M +60.8% Jan 1, 2014 Mar 31, 2014 10-K 2016-04-29
Q4 2013 $6.18B $1.84B +$822M +80.8% Oct 1, 2013 Dec 31, 2013 10-K 2016-04-29
Q3 2013 $5.36B $2.43B +$1.58B +185% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-24
Q2 2013 $3.78B $954M +$221M +30.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 $3.56B $951M +$157M +19.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $3.4B $1.02B +$360M +54.7% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $3.04B $855M +$366M +75.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-01
Q2 2012 $2.67B $733M +$242M +49.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $2.43B $795M +$304M +62.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $2.13B $658M +$94.5M +16.8% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $2.03B $488M +$154M +45.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 $1.88B $491M +$301M +158% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 $1.58B $490M +$287M +141% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 $1.29B $564M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 $335M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $190M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $203M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.